Ambuja & ACC jump post renewal of tech fees with Holcim
Ambuja & ACC jump post renewal of tech fees with Holcim

Ambuja & ACC jump post renewal of tech fees with Holcim

Anthony Fernandes Article rating: 5.0

The shares of Holcim-promoted cement companies, Ambuja Cements & ACC Ltd were trading in the green on Thursday after the companies received board approval for paying technology fees to their parent company, Holcim Limited.  

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.6

The market opened in green on December 24, 2020, overall volumes in futures & options currently stand at 3,40,93,286 contracts with a turnover of Rs. 28,84,493.46 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 4.1

The market opened in green on December 24, 2020, overall volumes in futures & options currently stand at 3,40,93,286 contracts with a turnover of Rs. 28,84,493.46 crore.

eClerx announces acquisition of Personiv; stock gains by nearly 22 per cent in a month
eClerx announces acquisition of Personiv; stock gains by nearly 22 per cent in a month

eClerx announces acquisition of Personiv; stock gains by nearly 22 per cent in a month

Deepti Shidore Article rating: 3.6

eClerx Services announced that it is acquiring Eclipse Global Holdings LLC (Personiv), which is an Austin, Texas-headquartered company having its operations in business process management & services, with a special focus on the outsourced accounting space.  

Caplin Point shines on getting USFDA nod for Etomidate injection
Caplin Point shines on getting USFDA nod for Etomidate injection

Caplin Point shines on getting USFDA nod for Etomidate injection

Apurva Joshi Article rating: 3.2

Caplin Point Laboratories’ subsidiary company, Caplin Steriles Limited has received final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Etomidate injection USP.

Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX
Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX

Aurobindo Pharma takes a step forward to cure COVID-19; collaborates with US company COVAXX

Shreya Chaware Article rating: 3.7

On Thursday, Aurobindo Pharma, a leading pharma company, signed an exclusive agreement with COVAXX, a US-based company for developing and commercialising COVID-19 vaccine i.e. UB-612, the first multitope peptide-based vaccine to fight COVID-19, for India and United Nations Children's Fund (UNICEF) agency. 

RSS
First23142315231623172319232123222323Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR